Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, presenting promising breakthroughs across different medical and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, far more trusted alternative for therapeutic use,